| 摘要 |
The present invention relates to uses of dual PPAR agonist compounds and delivery devices containing such compounds. The compounds are useful as pharmaceuticals for the treatment and/or prevention of VSMC proliferation, e.g., stenosis and restenosis, especially restenosis in diabetic patients.
|
